Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $530 Million - $623 Million
1,706,502 Added 2882.6%
1,765,702 $606 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $19 Million - $22.2 Million
59,200 New
59,200 $21.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mizuho Markets Americas LLC Portfolio

Follow Mizuho Markets Americas LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Markets Americas LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Markets Americas LLC with notifications on news.